Clinical trials
Completed Observational Atrial Fibrillation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
672 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 2 |
| 2002 | 5 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 10 |
| 2006 | 6 |
| 2007 | 8 |
| 2008 | 9 |
| 2009 | 19 |
| 2010 | 21 |
| 2011 | 28 |
| 2012 | 28 |
| 2013 | 41 |
| 2014 | 51 |
| 2015 | 53 |
| 2016 | 55 |
| 2017 | 57 |
| 2018 | 52 |
| 2019 | 48 |
| 2020 | 53 |
| 2021 | 37 |
| 2022 | 33 |
| 2023 | 22 |
| 2024 | 11 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 672 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 44 |
| Boehringer Ingelheim | 36 |
| Abbott Medical Devices | 18 |
| Bristol-Myers Squibb | 13 |
| Boston Scientific Corporation | 9 |
| University Hospital, Basel, Switzerland | 9 |
| Pfizer | 8 |
| Biotronik SE & Co. KG | 6 |
| The Cleveland Clinic | 6 |
| University of Turku | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 672 |
| Stroke | 82 |
| Arrhythmias, Cardiac | 55 |
| Heart Failure | 26 |
| Ischemic Stroke | 23 |
| Atrial Flutter | 21 |
| Cardiovascular Diseases | 17 |
| Myocardial Infarction | 17 |
| Venous Thrombosis | 16 |
| Hypertension | 15 |
Trials
Showing 1 to 25 of 672. Each trial links to its page on Pharma Observatory.
572 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.